Rajiv Dattatreya, MD

Board Certifications

• Internal Medicine
• Endocrinology, Diabetes, & Metabolism

Fellowship

Cleveland Clinic Foundation
Endocrinology

Rotating Internship

Jawaharlal Institute of Postgraduate Medicine Education & Research
Pondicherry, India

Residency

Albert Einstein College of Medicine of Yeshiva University
Internal Medicine

Post-graduate School

Postgraduate Institute of Medical Education
Chandigarh, India

Baylor at Irving- Active Staff
Medical City Las Colinas – Active Staff

• Endocrine Associates of Dallas & Plano, Present
• North Texas Diabetes and Endocrinology of lrving, 2021 N MacArthur Blvd, Ste 225, Irving, Tx- 75061, 07/2018
• Endocrinology, Diabetes and Metabolism Medical & Surgical Clinic of Irving, PA 2021 N. MacArthur 4/2009 – 04/2009
• Family Practice, Healthcare Associates of Irving, LLP 1110 Cottonwood Lane, Irving, TX 75038, 4/2007 – 04/2009
• North Texas Health Care Associates 2021 N. MacArthur Blvd, Irving, TX 75061, 02/2002 – 04/2007
• Diabetes Center of Southwest 10 Desta Drive, Midland, TX 79705, 09/2000 – 02/2002
• Multi-Specialty Medical Group 111 Coastal Way, Chesapeake, VA 23320, 03/1998 – 08/2000
• Multi-Specialty Medical Group Route 168 & Courthouse Rd Currituck, NC, 03/1998 – 08/2000
• Gap due to move to USA, vacation, 02/1992 – 06/1992
• St. Luke’s Hospital, Bradford, West Yorkshire, UK, 08/1991-01/1992
• Bradford Royal Infirmary Bradford, West Yorkshire, UK, 04/1991 – 07/1991
• Wrightington Hospital Wigan, Lancashire, UK, 08/1990-01/1991
• Severalls Hospital Colchester, Essex, UK 07/1990-08/1990
• St. Mary’s Hospital, Essex, UK, 04/1990 – 06/1990

American Association of Clinical Endocrinologists (AACE)
Texas Medical Association 2021
Dallas County Medical Society 202

• Texas State Board License 2000
• American Board of Internal Medicine 1995
• American Board of Internal Medicine Endocrinology 1997, Recertification 2007 and 2017
• Fellow, AACE 2002

Research and Publications

Poster Presentation

“Effect of Radioactive Iodine Treatment on Grave’s Ophthalmopathy,” American Thyroid Association meeting, Colorado Springs, Colorado, 1997

Research- Phase II-IV Studies

Short Term, Multicenter, Randomized, Open-Label, Parallel-Group Study Assessing the Pulmonary Effects of Chronically Dosed Inhaled or Subcutaneous Insulin Therapy. Pfizer A2171027

Efficacy and Safety of Exubera (inhaled insulin) Compared with Subcutaneous Human Insulin Therapy in Adult Subject with Type-2 Diabetes Mellitus:
A Two -year, Outpatient, Open-Label, Parallel-Group Comparative Trial. Pfizer A2171029

A Multi-national, Randomized, Double-blind, Placebo-Controlled, Force Titration, 2×2 Factorial Design Study of the Efficacy and Safety of Long Term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects with Impaired Glucose Tolerance (IGT). Novartis CDJN608B2302

Publication

Effect of 131 Iodine Therapy on the Course of Graves’ Ophthalmopathy:
A Quantitative Analysis of Extraocular Muscle Volumes Using Orbital Magnetic Resonance Imaging, Thyroid: 2001.

Speaker’s Bureau

AbbVie, Astra-Zeneca, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk Sanofi.

Dr. Dattatreya delivers lectures on health-related topics and educates health care professionals. He likes gardening, cooking, and music. He is married, with two teenage children.

Dr. Rajiv Dattatreya, originally from India, obtained a medical degree from Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India in 1986. He completed an Internal Medicine residency program at Albert Einstein College of Medicine, New York. Subsequently, he completed his Endocrinology fellowship at Cleveland Clinic, Ohio.

Dr. Dattatreya is board certified in Endocrinology, Diabetes, and Metabolism. He specializes in disorders of the Endocrine system, including Thyroid, Diabetes and metabolism, and osteoporosis. He is a Fellow of the American Association of Clinical Endocrinologists (AACE)